Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple injection boost recovery after C-Section?

NCT ID NCT07145619

Symptom relief Sponsor: MEHMET GÖKHAN TAFLAN Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times

Summary

This study looks at whether adding a TAP block (a numbing injection in the belly wall) to standard pain relief helps women recover better after a planned C-section. 150 women will be observed, with half getting the extra block. Researchers will measure recovery quality, pain, and how soon they can move and breastfeed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bilateral ultrasound-guided transversus abdominis plane (TAP) block
What this could lead to
If it works, this could point toward a simple way to improve recovery and reduce pain after cesarean delivery.
What could go wrong
This is an observational study, not a randomized trial, so results may be less reliable. It is also small and early, so findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

160 people

The number who actually took part.

Started

Sep 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women undergoing elective cesarean delivery under spinal anesthesia with intrathecal morphine at a tertiary university hospital. Two observational cohorts will be followed: one receiving only intrathecal morphine and the other receiving intrathecal morphine plus bilateral ultrasound-guided TAP block.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients aged 18-45 years * Singleton pregnancy * ASA physical status II-III * Scheduled elective lower segment cesarean delivery under spinal anesthesia with intrathecal morphine (ITM) as standard care * Able to understand study procedures, provide written informed consent, and reliably use IV PCA * Able to complete ObsQoR-10-T assessments (with trained assistance if needed) Exclusion Criteria: * Contraindication to spinal anesthesia or TAP block (e.g., infection at injection site, coagulopathy, allergy to local anesthetics) * Chronic opioid use or opioid/alfa-2 agonist intolerance * Severe preeclampsia, HELLP syndrome, significant hepatic or renal impairment * Urgent or emergent cesarean section (Category 1) * Cognitive impairment or communication difficulty preventing accurate assessment * Prior major abdominal surgery (other than previous cesarean delivery) * Body mass index (BMI) \> 40 kg/m² * Major psychiatric illness (e.g., major depressive disorder, generalized anxiety disorder, psychosis) that may affect pain perception or quality of recovery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstetric anesthesia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstetric anesthesia Postoperative pain management Recovery from anesthesia

Contacts and locations

Locations

  • Samsun University Training and Research Hospital

    Samsun, Samsun, 55090, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.